Virios Therapeutics Inc
Change company Symbol lookup
Select an option...
VIRI Virios Therapeutics Inc
TCBS Texas Community Bancshares Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
Go

Health Care : Biotechnology |
Company profile

Virios Therapeutics, Inc., formerly Virios Therapeutics, LLC., is a development-stage biotechnology company focused on advancing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). Its lead development candidate is IMC-1, which is a fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination antiviral therapy designed to synergistically suppress Herpes Simplex Virus-1 (HSV-1) activation and replication. Its HSV-1 root cause of chronic illnesses such as FM, irritable bowel disease (IBS), chronic fatigue syndrome and functional somatic syndrome. The Company is developing its initial candidate, IMC-1, for people who are suffering from fibromyalgia.

Closing Price
$6.15
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
60,939
0

Schlumberger Ltd. Stock Outperforms Competitors Despite Losses On The Day

5:20 pm ET June 10, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Schlumberger Ltd. (SLB) slid 1.93% to $47.21 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 2.91% to 3,900.86 and Dow Jones Industrial Average falling 2.73% to 31,392.79. This was the stock's second consecutive day of losses. Schlumberger Ltd. closed $2.62 below its 52-week high ($49.83), which the company achieved on June 8th.

Despite its losses, the stock outperformed some of its competitors Friday, as Baker Hughes Co. (BKR) fell 2.36% to $35.23, Halliburton Co. (HAL) fell 4.07% to $40.49, and NOV Inc. (NOV) fell 2.77% to $20.00.true Trading volume (11.3 M) remained 1.1 million below its 50-day average volume of 12.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2022.

	

(END) Dow Jones Newswires

June 10, 2022 17:20 ET (21:20 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.